Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Semaglutide 2.4mg for Low Responders After Bariatric Surgery

Zuyderland Medisch Centrum · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
bariatricsurgeryglpobesitysemaglutideweightgainweightloss
obesity, obesity, morbid, weight gain, semaglutide, glp-1, bariatric surgery, weight loss, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 907736
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.